Momenta Pharmaceuticals Inc (NASDAQ:MNTA)
| 10.59 Real-Time Quote |  -0.49 / -4.42%Today’s Change | 9.85 Today|||52-Week Range 19.90 | -40.10% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Assets | Cash | 100.7M | 17.5M | 53.0M | 29.8M | |
| Short Term Investment Cash | 78.7M | -51.4M | 3.7M | -23.2M | ||
| Cash & Short Term Investments | 141.8M | 365.9M | 340.6M | 245.7M | ||
| Receivables | Receivables | 59.8M | 30.9M | 11.6M | 16.5M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 1.8M | 2.5M | 5.0M | 3.4M | |
| Current Assets | 203.3M | 399.4M | 357.2M | 265.6M | ||
| Total Assets | Property, Plant and Equipment - Gross | 27.2M | 34.7M | 50.1M | 58.6M | |
| Depreciation | -18.2M | -21.4M | -27.7M | -33.9M | ||
| Intangible Assets | 2.5M | 7.8M | 6.7M | 5.7M | ||
| Other Assets | 2.5M | 8.2M | 7.1M | 5.8M | ||
| Total Assets | 227.6M | 420.9M | 406.6M | 316.8M | ||
| Liabilities | Accounts Payable | 4.4M | 4.7M | 3.6M | 6.3M | |
| Short Term Debt | 1.7M | 0.00 | 0.00 | 0.00 | ||
| Accrued Expenses | 4.7M | 4.0M | 4.3M | 4.8M | ||
| Other Current Liabilities | 7.1M | 6.2M | 9.3M | 8.9M | ||
| Other Liabilities | 17.7M | 16.0M | 18.2M | 21.9M | ||
| Total Liabilities | Other Liabilities | 51.0K | 51.0K | 712.0K | 1.0M | |
| Total Liabilities | 21.5M | 17.8M | 46.1M | 47.0M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 206.1M | 403.1M | 360.5M | 269.8M | ||
| Total Shareholder Equity | 206.1M | 403.1M | 360.5M | 269.8M | ||
| Share Information | Common Shares Outstanding | 49.7M | 51.3M | 51.7M | 52.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
.
